JANX
Janux Therapeutics Inc
16.70$
+1.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| -0.09 | -0.10 | -0.41 | -1.04 | -1.15 | -0.82 | -1.33 | |
| 0.00 | 0.00 | 0.00 | 0.02 | 0.04 | 0.04 | 0.03 | |
| 0.00 | 0.00 | 0.17 | 0.41 | 0.45 | 0.61 | 0.65 | |
| 0.01 | 0.05 | 0.16 | 0.41 | – | – | – | |
| 0.00 | 0.01 | 0.21 | 0.10 | -0.15 | 0.01 | 0.11 | |
| 0.04 | 0.04 | 0.04 | 0.16 | 0.04 | 0.01 | 0.02 | |
| -8.19 | -8.19 | -8.27 | 1.41 | -0.94 | -4.80 | -4.86 | |
| – | – | 4.95 | – | – | – | -0.01 | |
| 0.10 | 0.06 | 4.38 | 0.56 | – | – | – | |
| 0.10 | 0.28 | 9.37 | 0.01 | 1.35 | 13.27 | 0.08 | |
| 0.00 | 0.17 | 0.69 | 0.38 | -0.73 | 7.65 | -6.10 | |
| -0.09 | -0.10 | -0.45 | -1.19 | -1.19 | -0.82 | -1.34 |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.